© 2023 Trustees of Boston University
Get real time update about this post category directly on your device, subscribe now.
Harvard Business Review recently published an article by Tal Gross, Associate Professor, discussing ways insurers can benefit from copayments and reduce their downside.
Read moreRadio Health Journal recently published a segment featuring Rena Conti, Associate Professor of Markets, Public Policy, and Law, discussing her recent research focused on generic drug production.
Read moreLucia Ryll, fourth year medical student and Health Sector MBA candidate from Boston University, recently penned an op-ed for Medpage Today that speaks to the potential benefits and pitfalls of...
Read moreMedpage Today recently published an article co-authored by Rena Conti, Associate Professor of Markets, Public Policy, and Law, discussing how a proposed insulin cost cap will affect different individuals.
Read moreWe often hear that “necessity is the mother of invention”, so it is no surprise that the Covid-19 pandemic – which upended, well, just about everything – set off a...
Read moreAn unassuming duct tape-and-cardboard construction known as a Corsi-Rosenthal box – is playing an important part in the fight against COVID-19. The story of how it came to be also...
Read moreHealth Affairs Forefront recently published insight from their short series, “Prescription Drugs: Promoting Affordability and Innovation,” a conference hosted by Rena Conti, Associate Professor of Markets, Public Policy, and Law.
Read moreBU Today’s podcast ‘Question of the Week’ recently interviewed Rena Conti, Associate Professor of Markets, Public Policy, & Law, on her surprising findings related to insurance claims and reimbursement data....
Read moreHow has the COVID-19 pandemic shaped our ability to utilize Artificial Intelligence, and how have we adapted AI to respond to the pandemic in turn? In this Insights@Questrom blog post,...
Read moreNature Human Behavior recently published a study co-researched by Chiara Longoni, Assistant Professor of Marketing, and Carey Morewedge, Professor of Marketing on their findings examining peoples’ understanding of medical AI...
Read moreHow can the pharmaceutical industry balance innovation with affordability? In this Expert Take, Questrom's Rena Conti, Dean's Research Scholar and Associate Professor, Markets, Public Policy, and Law analyses how drug...
Read moreIn regulating tobacco products, how should the FDA balance the goals of preventing youth consumption versus helping adult smokers quit? This question is explored for Insights@Questrom by Bobbi Clarke, Questrom...
Read moreFuturity recently published insight co-authored by Rena Conti, Associate Professor in the Department of Markets, Public Policy and Law, on the topic of her recent research study on the costs...
Read moreFactCheck recently published insight from Rena Conti, Associate Professor in the Department of Markets, Public Policy and Law, on the topic of TV ads portraying false information regarding Medicare drug...
Read moreDiagnostic care health applications, enabled by artificial intelligence (AI), have become more widely available directly to consumers, including on mobile devices. However, consumers have been slow to adopt the use...
Read moreIn Part 2 of this seven part series, Darrell Griffin from the Institute for Health Systems Innovation & Policy, sits down with Dr. Brian Jack from BU School of Medicine,...
Read moreWhat impact will telemedicine and digital technology have on the U.S. healthcare system? Will telemedicine continue to be popular after COVID? What types of medicine are feasible virtually? Abraham (Avi)...
Read moreA recent survey conducted over social media by Abraham (Avi) Seidmann, Everett W. Lord Distinguished Faculty Scholar and Professor of Information Systems at Boston University Questrom School of Business, looked...
Read moreMany hospitals are struggling during COVID as they've had to shut down other wings to keep COVID patients safe. Do you forecast any hospitals merging to stay afloat? Any other...
Read moreA new survey of more than 6,500 U.S. blood cancer patients and survivors reveals only half are likely to get a COVID vaccine while one in three is unsure. The...
Read moreAs pharmaceutical companies and politicians scramble to disseminate the COVID-19 vaccine, one thing has become clear – accessibility is not equal. Insights@Questrom spoke with Professor Joseph Restuccia to learn what...
Read moreThe nation’s leading experts in biopharmaceutical innovation and pricing reform recently convened for a virtual discussion exploring the relationship between innovation and product pricing. Hosted by Questrom's Rena Conti, the...
Read moreWhat impact has the pandemic had on the current US health insurance system? What bottlenecks/constraints have there been to care, and are there ways to relieve them? How could this...
Read morePfizer and Moderna are working rapidly to roll out the COVID-19 vaccine. Insights@Questrom spoke with Marcus Bellamy, Assistant Professor, Operations & Technology Management, to learn how their supply chains are...
Read moreA new study suggests that up to a third of "excess deaths" in 2020 may not be attributable directly to COVID, but to healthcare disruptions resulting from the resources needed...
Read moreInitial results for the Pfizer vaccine suggest that the vaccine is 95% effective. Eric Jacquier, clinical professor of finance, explains how this relatively small test sample can be used to...
Read moreIn this Q&A, Questrom Magazine talks with Jonathan Woodson and Anita Tucker about improving healthcare coverage, fixing supply issues, and tracking future outbreaks.
Read moreQuestrom’s healthcare experts Avi Seidman and Jonathan Woodson, MD, MSS, consider COVID-19 as a watershed moment for healthcare. The two recount the pandemic as a time of digital domination, exposing...
Read moreJoin SV Health Investors' Eugene Hill (Questrom’80) for a discussion that tackles the evolution in healthcare technology, market enablers and barriers, and why telemedicine might be a lasting facet of...
Read moreIn a new piece in Psychology Today, organizational psychologist and Questrom Professor Bill Kahn dives into what that stress means, how to enable health care workers to remain as resilient...
Read moreNew research from BU Questrom's Rena Conti delves into the Affordable Care Act's effect on prescription drugs and what might come next.
Read moreSmokers’ cravings for cigarettes are strong on their own, but work by Questrom and Harvard researchers suggests one emotion can trigger an even more acute desire to light up.
Read moreEven though medical AI can perform with expert-level accuracy and deliver cost-effective care at scale, why do patients overwhelmingly prefer to be seen and diagnosed by humans?
Read moreQuestrom Executive Dining Rooms, 595 Commonwealth Avenue, Fourth Floor, Boston, MA, 02215
© 2023 Trustees of Boston University